Antioxidants, supplements, and Parkinson's disease

Annals of Pharmacotherapy

Volumn 40, Issue 5, 2006, Pages 935-938

  Weber, Cynthia A ^a   Ernst, Michael E ^b,c  

^a UNIVERSITY OF IOWA   (United States)

^b Department of Psychiatry   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Antioxidants; Coenzyme Q10; Glutathione; Parkinson's disease

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARBIDOPA; CAROTENOID; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DECARBOXYLASE INHIBITOR; DOPAMINE; ENTACAPONE; FREE RADICAL; GLUTATHIONE; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; PLACEBO; POLYUNSATURATED FATTY ACID; PRAMIPEXOLE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROPINIROLE; SELEGILINE; TOCOPHEROL; UBIDECARENONE; VITAMIN;

CLINICAL TRIAL; DAILY LIFE ACTIVITY; HUMAN; META ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; REVIEW; SUBSTANTIA NIGRA; SUPPLEMENTATION;

ANTIOXIDANTS; CLINICAL TRIALS; DIETARY SUPPLEMENTS; GLUTATHIONE; HUMANS; PARKINSON DISEASE; TOCOPHEROLS; UBIQUINONE; VITAMINS;

EID: 33646773864     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G551     Document Type: Review

References (18)

1. Parkinson's disease: hope through research. National Institute of Neurological Disorders and Stroke. www.ninds.nih.gov/disorders/parkinsons_ disease/detail_parkinsons_disease.htm (accessed 2005 June 1).
2. Olanow CW, Schapira AH, Agid Y. Neuroprotection for Parkinson's disease: prospects and promises. Ann Neurol 2003;53(suppl 3):S1-2.
3. Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with Parkinson's disease. Neurology 2001;57:790-4.
4. Sohmiya M, Tanaka M, Tak NW, et al. Redox status of plasma CoQ10 indicates elevated systemic oxidative stress in Parkinson's disease. J Neurol Sci 2004;223:161-6.
5. Schapira AHV, Olanow CW. Neuroprotection in Parkinson disease; mysteries, myths, and misconceptions. JAMA 2004;291:358-64.
6. Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early PD. N Engl J Med 1993;328:176-83.
7. Zhang SM, Hernan MA, Chen H, Spiegelman D, Willett WC, Ascherio A. Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk. Neurology 2002;59:1161-9.
8. Etminan M, Gill SS, Samir A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis. Lancet Neurol 2005;4:362-5.
9. Olanow CW. Dietary vitamin E and Parkinson's disease: something to chew on. Lancet Neurol 2003;2:74.
10. Matsubara T, Azuma T, Yoshida S, Yamagami T. Serum coenzyme Q10 level in Parkinson syndrome. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and clinical aspects of coenzyme Q. New York: Elsevier Science, 1991:159-66.
11. Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease; evidence of slowing of the functional decline. Arch Neurol 2002;59:1541-50.
12. Shults CW, Beal MF, Song D, Fontaine D. Pilot trial of high dosages of CoQ10 in patients with Parkinson's disease. Exp Neurol 2004;188:491-4.
13. Muller T, Buttner T, Gholipour AF, Kuhn W. Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease. Neurosci Lett 2003;341:201-4.
14. Strijks E, Kremer HPH, Horstink MWIM. Q10 therapy in patients with idiopathic parkinson's disease. Mol Aspects Med 1997;18(suppl):237-40.
15. Horstink MW, van Engelen BG. The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic (letter). Arch Neurol 2003;60:1170-2.
16. Dexter DT, Sian J, Rose S, et al. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 1994;35:38-44.
17. Riederer P, Sofic E, Raush WD, et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 1989;52:515-20.
18. Sechi G, Deledda MG, Bua G, et al. Reduced intravenous glutathione in the treatment of early Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:1159-70.